Maria Werner-Wasik, MD
Room G-301, Bodine Center
Philadelphia, PA 19107
(215) 955-0412 fax
Most Recent Peer-reviewed Publications
- A randomized trial of bevacizumab for newly diagnosed glioblastoma
- Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme
- Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.
- Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
- Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: Maintenance of tumor control with improved hearing preservation
Wroclaw Medical Academy, Wroclaw, Poland
Tufts-New England Medical Center, Boston (3 years)
Hospital of the University of Pennsylvania, Philadelphia, PA (1 year)
American Board of Radiology (Radiation Oncology), 1994
1995 - 2001: Assistant Professor
2001 - 2009: Associate Professor
2010 - Present: Professor
Research and Clinical Interests
I am a board certified radiation oncologist, specializing in thoracic and central nervous system malignancies. I am particularly interested in the delicate balance between therapeutic intensification and toxicity management, as well as in PET-based response to radiation therapy in lung cancer. I also serve as a Co-Director of the Brain Tumor Center.
In 2009 I was appointed the Institutional Principal Investigator for the Radiation Therapy Oncology Group (RTOG) at Thomas Jefferson University & Hospitals and in 2011, the Vice Chair of the RTOG Publications Committee. I have been the principal investigator of several clinical trials which help define the standard of care for lung cancer.
I frequently hold lectures on lung cancer or brain tumors at national and international conferences such as the American Society for Therapeutic Radiation Oncology (ASTRO), the American Society for Clinical Oncology (ASCO), and the International Association for the Study of Lung Cancer (IASLC) World Conference.
I also serves as an Oral Examiner during the Radiation Oncology Specialty Board annual examination in Louisville, KY.
In the Radiation Oncology Department, I lead the program of Stereotactic Body Radiation Therapy (SBRT) for early stage lung cancer and lung metastases. This is an extension of our Departments long term experience in brain stereotactic radiosurgery and radiotherapy for both benign and malignant brain tumors, as well as tumors metastatic to the spine.
Between 2009 and 2013, I have been awarded several "Best Doctor" titles (Philadelphia Top Doctor; America's Top Doctors for Cancer; America's Top Doctors).